The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109   23,152,516 3,030,434 SH   SOLE   3,030,434 0 0
AKOYA BIOSCIENCES INC COM 00974H104   17,683,302 1,847,785 SH   SOLE   1,847,785 0 0
NATERA INC COM 632307104   35,407,284 881,436 SH   SOLE   881,436 0 0
CYTEK BIOSCIENCES INC COM 23285D109   13,273,000 1,300,000 SH   SOLE   1,300,000 0 0
MAXCYTE INC COM 57777K106   17,608,500 3,225,000 SH   SOLE   3,225,000 0 0
DANAHER CORPORATION COM 235851102   4,976,625 18,750 SH   SOLE   18,750 0 0
GUARDANT HEALTH INC COM 40131M109   23,621,704 868,445 SH   SOLE   868,445 0 0
SONENDO INC COM 835431107   13,140,994 4,643,461 SH   SOLE   4,643,461 0 0